---
schema_version: "secwatch.filing_event.v1"
accession: "0002023658-25-000063"
form_type: "8-K"
ticker: "BCAX"
cik: "0002023658"
company_name: "Bicara Therapeutics Inc."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:49:49.533621+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Bicara Therapeutics subleases 9,682 sq ft of HQ office space through June 2027

## Summary
- Sublease covers approx. 9,682 sq ft at 116 Huntington Ave, Boston, MA.
- Base rent: $532,510/yr (Year 1), $543,160.20 (Year 2), $554,023.40 (Year 3).
- Sublease term ends June 30, 2027; security deposit of $45,263.35 required.
- Effective upon consent of Columbia Reit – 116 Huntington, LLC received June 4, 2025.

## SEC filing metadata
- accession: 0002023658-25-000063
- form_type: 8-K
- ticker: BCAX
- cik: 0002023658
- company_name: Bicara Therapeutics Inc.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023658/000202365825000063/0002023658-25-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023658/000202365825000063/bcax-20250602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002023658-25-000063
- JSON: https://secwatch.observer/filing/0002023658-25-000063.json
- Plain text: https://secwatch.observer/filing/0002023658-25-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.